Full model | Reduced model | |||||||
---|---|---|---|---|---|---|---|---|
HR | %95 CI | p | HR | %95 CI | p | |||
Age (years) | ||||||||
<65* | 0.047 | 0.025 | ||||||
65-69 | 0.6 | 0.2 | 1.5 | 0.252 | 0.5 | 0.2 | 1.4 | 0.189 |
70-74 | 1.2 | 0.5 | 2.5 | 0.710 | 1.1 | 0.5 | 2.4 | 0.773 |
≥75 | 3.6 | 1.2 | 11.0 | 0.023 | 3.0 | 1.3 | 6.8 | 0.009 |
Comorbidity | ||||||||
No* | ||||||||
Yes | 2.3 | 1.3 | 4.1 | 0.003 | 2.3 | 1.4 | 4.0 | 0.002 |
Stage | ||||||||
1* | <0.001 | <0.001 | ||||||
2 | 2.0 | 0.8 | 5.0 | 0.149 | 2.1 | 0.9 | 4.9 | 0.072 |
3 | 6.4 | 2.4 | 16.7 | <0.001 | 7.1 | 3.0 | 16.4 | <0.001 |
4 | 21.5 | 6.5 | 70.6 | <0.001 | 22.5 | 8.7 | 58.4 | <0.001 |
Histologic grade | ||||||||
1* | 0.085 | 0.075 | ||||||
2 | 1.8 | 0.8 | 4.2 | 0.152 | 1.8 | 0.8 | 4.2 | 0.149 |
3 | 2.5 | 1.1 | 5.8 | 0.033 | 2.5 | 1.1 | 5.8 | 0.030 |
Surgical treatment | ||||||||
Yes* | ||||||||
No | 1.1 | 0.3 | 3.3 | 0.899 | ||||
Chemotherapy | ||||||||
Yes* | ||||||||
No | 1.2 | 0.5 | 3.1 | 0.680 | ||||
Radiotherapy | ||||||||
Yes* | ||||||||
No | 1.2 | 0.3 | 3.9 | 0.819 | ||||
−2 log likelihood ratio | 788.363 | 788.659 |